These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Monopolies, Maricopa, and marketing: a case study. Perkins J; Mercer A; McClary C Hosp Health Serv Adm; 1986; 31(4):34-44. PubMed ID: 10277339 [TBL] [Abstract][Full Text] [Related]
5. Antitrust and the new competition in health care: excerpts. Ginsburg DH Med Prod Sales; 1986 Apr; 17(4):39-42. PubMed ID: 10276459 [No Abstract] [Full Text] [Related]
7. The FTC and provider-controlled PPO price negotiations. Miles JJ Health Law Vigil; 1988 Jan; 11(3):6-10. PubMed ID: 10285716 [No Abstract] [Full Text] [Related]
8. Non-physician providers vs. Foundation Health Plan--a major restraint-of-trade case study. Ashley L; Kelly P Nurse Pract; 1987 Nov; 12(11):50-3, 56. PubMed ID: 3696538 [No Abstract] [Full Text] [Related]
9. Court: Indiana Blues may adopt PPO plan without antitrust scrutiny. Allen HS; Rothschild IS Health Law Vigil; 1986 Apr; 9(8):4-5. PubMed ID: 10278389 [No Abstract] [Full Text] [Related]
10. Antitrust and physician payment. Pollard MR N C Med J; 1984 Apr; 45(4):227-31. PubMed ID: 6585668 [No Abstract] [Full Text] [Related]
11. FTC strives for high profile in health care related reform efforts. Cronin C Bus Health; 1987 Jun; 4(8):55. PubMed ID: 10282050 [No Abstract] [Full Text] [Related]
12. The antitrust swamp: how can healthcare professionals avoid it? Weller CD Healthc Financ Manage; 1982 Oct; 36(10):26-8, 30-6. PubMed ID: 10315211 [No Abstract] [Full Text] [Related]
13. Proposed FTC consent order first to prohibit PPO price-fixing and concerted negotiations. Miles JJ Health Law Vigil; 1988 Jan; 11(2):9-10, 14. PubMed ID: 10285312 [No Abstract] [Full Text] [Related]
14. Alternative delivery systems are focus of antitrust scrutiny. Scammon DL; Fuller DA; Sheffet MJ J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715 [No Abstract] [Full Text] [Related]
16. Why the feds drove these doctors out of business. Hung K Med Econ; 1985 Apr; 62(7):92-4, 99, 102 passim. PubMed ID: 10278314 [No Abstract] [Full Text] [Related]
17. Vertical restraints and powerful health insurers: exclusionary conduct masquerading as managed care? Miller FH Law Contemp Probl; 1988; 51(2):195-236. PubMed ID: 10295963 [No Abstract] [Full Text] [Related]
18. Are PPOs a competitive force or antitrust risk? Enders RJ Healthc Financ Manage; 1986 May; 40(5):52-60. PubMed ID: 10276171 [TBL] [Abstract][Full Text] [Related]
19. Federal antitrust agencies send mixed signals to PPOs. Enders RJ Health Care Law Newsl; 1986 Jul; 1(1):12-4. PubMed ID: 10277502 [No Abstract] [Full Text] [Related]
20. "Free choice" as a restraint of trade in American health care delivery and insurance. Weller CD Spec Law Dig Health Care (Mon); 1985 May; 7(3):5-46. PubMed ID: 10300085 [No Abstract] [Full Text] [Related] [Next] [New Search]